Celico (CEO Kim Jeong-seok ) announced that it had received ‘bioimplantable ultrasonic wireless charging technology ‘ from the Electronics and Telecommunications Research Institute of Korea ( ETRI) ICT Creativity Research Institute (Director Dr. Seong-won Kang ) .
Through this ETRI technology transfer, Celico has become the first in Korea to possess both RF wireless charging and ultrasonic wireless charging technology . In addition, through the transferred technology, we plan to develop a low-power, high-performance electropharmaceutical platform that takes biosafety into consideration in the future .
Ultrasonic wireless charging refers to a device that supplies power to the body using sonic vibrations . In the case of implantable electronic medicine, since it is inserted into the body, it must receive a stable power supply from the outside . Ultrasonic wireless charging has high efficiency and can minimize heat generation and external interference . This overcomes the shortcomings of the existing magnetic induction coil-based RF wireless charging method: heat generation , radio , and interference from external wireless devices such as Bluetooth .
Celico is an innovative medical device startup that develops an implantable electronic medicine platform , and is developing an electronic eye product, an artificial retina medical device for visually impaired people who have lost their eyesight due to retinal disease . Celico has secured neuromorphic image sensor technology to replace optic cells damaged by disease , and is currently focusing on miniaturizing the product and improving resolution to enable electronic eye transplantation for the visually impaired .
“Through this technology transfer , we will be able to supply not only the electronic eye we are currently developing, but also a wireless charging solution optimized for the part of the human body where it will be inserted, ” said Kim Jeong-seok, CEO of Celico. “By collaborating with ETRI, we will become the world’s best electronic medicine platform company.” “That is the goal, ” he said .
ETRI research director Dr. Seong-gyu Lee said, “This research developed the original technology with support from the KIAT international joint research project (Project title : Development of sustainable power modules based on ultrasonic wireless power transmission for medical devices implanted in the human body ) , and has a social and technological ripple effect. “I am glad that it has been applied to the large implantable electronic medicine field, ” he said. “We will continue to cooperate with Cellico, which possesses core technology, to advance electronic medicine by commercializing ultrasonic wireless charging technology.” “He said .
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asia Innovation Hub Pangyo Techno Valley 2021’ news